menu
    • menu

    Company profile for Opthea

    NEW Drugs in Dev: 3
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Opthea is committed to improving vision in patients suffering from retinal eye diseases. We are developing a novel therapeutic called OPT-302, a VEGF-C/D ‘trap’, to be used in conjunction with existing standard of care anti-VEGF-A therapies. OPT-302 has the potential to address the unmet medical need of wet AMD and DME patients, many of whom respond sub-optimally or become refractory to existing therapies for these debilit...
    Opthea is committed to improving vision in patients suffering from retinal eye diseases. We are developing a novel therapeutic called OPT-302, a VEGF-C/D ‘trap’, to be used in conjunction with existing standard of care anti-VEGF-A therapies. OPT-302 has the potential to address the unmet medical need of wet AMD and DME patients, many of whom respond sub-optimally or become refractory to existing therapies for these debilitating diseases. We are advancing the clinical development of OPT-302 in Phase 2 wet AMD and DME clinical trials.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OptheaAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Suite 0403, Level 4, 650 Chapel Street, South Yarra, Victoria 3141
    Telephone
    Telephone
    +613 9826 0399
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://opthea.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/opthea
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/opthea1

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Circadian Risk Raises $6 Million In Oversubscribed Series A Round
    Circadian Risk Raises $6 Million In Oversubscribed Series A Round

    24 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/circadian-risk-raises-6-million-in-oversubscribed-series-a-round-302695430.html

    PR NEWSWIRE
    24 Feb 2026
    Share Share
    Opthea Cuts 85% of Staff, Including CEO
    Opthea Cuts 85% of Staff, Including CEO

    19 Aug 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/opthea-still-reeling-eye-disease-flops-ramps-layoffs-85-and-loses-ceo

    FIERCE BIOTECH
    19 Aug 2025
    Share Share
    Opthea Provides Corporate Update
    Opthea Provides Corporate Update

    18 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/18/3135369/0/en/Opthea-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    18 Aug 2025
    Share Share
    Opthea lays off 65% of staff after back-to-back phase 3 flops
    Opthea lays off 65% of staff after back-to-back phase 3 flops

    11 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/opthea-lays-65-staff-after-back-back-phase-3-flops

    FIERCE BIOTECH
    11 Apr 2025
    Share Share
    Opthea Announces Decision to Discontinue Wet AMD Trials
    Opthea Announces Decision to Discontinue Wet AMD Trials

    31 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/31/3051929/0/en/Opthea-Announces-Decision-to-Discontinue-Wet-AMD-Trials.html

    GLOBENEWSWIRE
    31 Mar 2025
    Share Share
    Opthea Announces COAST Phase 3 Trial Topline Results
    Opthea Announces COAST Phase 3 Trial Topline Results

    24 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/24/3047520/0/en/Opthea-Announces-COAST-Phase-3-Trial-Topline-Results.html

    GLOBENEWSWIRE
    24 Mar 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search